Thrombocytopenia risks in ARDS COVID-19 patients treated with high-dose linezolid during vvECMO therapy: an observational study

Наслов

Thrombocytopenia risks in ARDS COVID-19 patients treated with high-dose linezolid during vvECMO therapy: an observational study

Идентификатор

/unibl/sci/idNaucniRad:35094

Тип

Датум

Библиографски цитат

P. Kovačević, D. Milaković, T. Kovačević, V. Barišić, S. Dragić, B. Zlojutro, B. Miljković, K. Vučićević, Z. Rizwan, Thrombocytopenia risks in ARDS COVID-19 patients treated with high-dose linezolid during vvECMO therapy: an observational study, NAUNYN-SCHMIEDEBERG`S ARCHIVES OF PHARMACOLOGY, Vol. 397, pp. 7747 - 7756, May, 2024

Референца

Почетна страница

7747

Крајња страница

7756

Је дио

NAUNYN-SCHMIEDEBERG`S ARCHIVES OF PHARMACOLOGY

Листа аутора

Position: 133319 (10 views)